Edwards Lifesciences Corporation (EW)
$90.50+0.79%Close
BUYBULL · day 11
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $52.1B
- Avg volume
- 4.9M
- Beta
- 0.85
- P/E (TTM)
- 52.01
- Short % float
- 1.77%
- Days to cover
- 1.8
- SI change
- -11.5%
- 1W
- -0.34%
- 1M
- +9.52%
- 3M
- +5.50%
- YTD
- +6.06%
- vs SPY 1W
- +0.85%
- vs SPY 1M
- +6.20%
- vs SPY 3M
- +3.11%
- vs SPY YTD
- -5.70%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- WSTSELLWest Pharmaceutical Services, Inc.BULLQ 18$353.32+0.07%
- TBPHBUYTheravance Biopharma, Inc.BULLQ -1$17.01+0.00%
- GDRXBUYGoodRx Holdings, Inc.RECOVERYQ -18$3.44-0.29%
- HLNBUYHaleon plcBULLQ 19$10.16+1.60%
- UTMDBUYUtah Medical Products, Inc.BULLQ 9$71.62+0.10%
- LQDASELLLiquidia CorporationCRISISQ 24$70.27+2.40%
- AMGNBUYAmgen Inc.BULLQ 21$443.84+1.03%
- CORBUYCencora, Inc.RECOVERYQ 20$323.77+1.80%
- HUMSELLHumana Inc.BEARQ 10$386.61+2.04%
- LLYBUYEli Lilly and CompanyBULLQ 17$1247.92-0.60%
- UFPTBUYUFP Technologies, Inc.BULLQ 23$305.39-1.21%
- UNHSELLUnitedHealth Group IncorporatedBEARQ 16$398.76+2.22%
Industry peers
FMP comparable companies · ranked by market cap
- ARGXBUYargenx SE$64.6BBULLQ 59$1038.12-2.76%
- CAHSELLCardinal Health, Inc.$53.5BBEARQ 12$228.46+1.25%
- BDXBUYBecton, Dickinson and Company$51.7BBULLQ 18$187.62-0.66%
- ABUYAgilent Technologies, Inc.$44.1BBULLQ 15$156.30-3.50%
- HLNBUYHaleon plc$43.5BBULLQ 19$9.87+1.60%
- VEEVBUYVeeva Systems Inc.$40.7BRECOVERYQ 21$250.53+0.23%
- ALCBUYAlcon Inc.$35.6BRECOVERYQ 11$72.93+0.10%
- DXCMBUYDexCom, Inc.$34.0BBULLQ 21$90.22-1.39%
- STEBUYSTERIS plc$23.0BRECOVERYQ 11$235.74-0.03%
- BRKRSELLBruker Corporation$9.1BRECOVERYQ 8$59.92-4.33%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 28
- VALUE
- 9
- GROWTH
- 61
- GARP
- 14
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC5.8%
REV YoY-
ROE9.7%
EPS YoY-
ROA7.2%
GROSS78
OP28
NET15
[VALUATION]
P/E TTM52.01
P/E FWD-
SECTOR PE22.66
INDUSTRY PE24.61
P/B4.91
P/FCF-
EV/EBITDA32.41
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E6.63
ALTMAN Z-
CURR RATIO4.52
ND/EBITDA-
BETA0.85
